← Back to Clinical Trials
Recruiting NCT07118748

NCT07118748 Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07118748
Status Recruiting
Phase —
Sponsor University Hospital, Bordeaux
Condition Acute Cystitis
Study Type INTERVENTIONAL
Enrollment 506 participants
Start Date 2026-05-19
Primary Completion 2026-11

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Share making decision toolDelegation protocol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 506 participants in total. It began in 2026-05-19 with a primary completion date of 2026-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this trial is to demonstrate that when treating acute cystitis without risk of complication, pharmacists may use share Decision Making tool to help patients to better understand the stakes of taking antibiotics and adapt the management of the delegation protocol. This will select patients in need of antibiotics and preserve the full-capacities of non-treated one.

Eligibility Criteria

Inclusion Criteria: * woman, * symptom of acute cystitis without risk of complication, * affiliated to the french public welfare system, * signed consent. Exclusion Criteria: * anomaly of the urinary canal, * pregnancy, more than 3 cystitis during the last year, * cancer, * immunosuppression, * hemopathy, * fever, * back-pain, * severe renal failure, * refuse to give consent and previously participate to the study, * under guardianship.

Contact & Investigator

Central Contact

Yves-Marie VINCENT, MD

✉ yves-marie.vincent@u-bordeaux.fr

📞 05 57 57 13 11

Frequently Asked Questions

Who can join the NCT07118748 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Acute Cystitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07118748 currently recruiting?

Yes, NCT07118748 is actively recruiting participants. Contact the research team at yves-marie.vincent@u-bordeaux.fr for enrollment information.

Where is the NCT07118748 trial being conducted?

This trial is being conducted at Aire-sur-l'Adour, France, Arès, France, Bon-Encontre, France, Bordeaux, France and 11 additional locations.

Who is sponsoring the NCT07118748 clinical trial?

NCT07118748 is sponsored by University Hospital, Bordeaux. The trial plans to enroll 506 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology